- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x FE2: FE (II) ION(Non-covalent)
- 90 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: S.144, N.148
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: P.161, S.162, S.163
Ligand excluded by PLIPSO4.7: 6 residues within 4Å:- Chain A: T.76, Q.77
- Chain B: K.78, G.80, K.81, V.82
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain B: K.50, S.163, T.164
- Ligands: FEC.6
Ligand excluded by PLIPSO4.11: 2 residues within 4Å:- Chain B: S.144, N.148
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain B: K.114
- Chain C: K.114
- Chain H: K.114
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: P.161, S.162, S.163
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain C: K.50, S.162, S.163, T.164
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain C: S.144, N.148
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain C: P.161, S.162, S.163
Ligand excluded by PLIPSO4.22: 6 residues within 4Å:- Chain D: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.19
Ligand excluded by PLIPSO4.23: 2 residues within 4Å:- Chain D: N.4, R.5
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain D: S.144, N.148
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain D: P.161, S.162, S.163
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain D: K.114
- Chain E: K.114
- Chain W: K.114
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain E: K.50, T.164, G.165
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain E: N.4, R.5
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain E: S.144, K.147, N.148
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain E: P.161, S.162, S.163
Ligand excluded by PLIPSO4.36: 5 residues within 4Å:- Chain F: K.50, S.163, T.164, G.165
- Ligands: FEC.33
Ligand excluded by PLIPSO4.37: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.87, SO4.137
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain F: P.161, S.162, S.163
Ligand excluded by PLIPSO4.41: 5 residues within 4Å:- Chain G: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain G: N.4, R.5, E.6
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain G: S.144, K.147, N.148
Ligand excluded by PLIPSO4.44: 3 residues within 4Å:- Chain G: P.161, S.162, S.163
Ligand excluded by PLIPSO4.48: 5 residues within 4Å:- Chain H: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.49: 2 residues within 4Å:- Chain H: S.144, N.148
Ligand excluded by PLIPSO4.50: 3 residues within 4Å:- Chain H: P.161, S.162, S.163
Ligand excluded by PLIPSO4.53: 5 residues within 4Å:- Chain I: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.54: 2 residues within 4Å:- Chain I: S.144, N.148
Ligand excluded by PLIPSO4.55: 3 residues within 4Å:- Chain I: P.161, S.162, S.163
Ligand excluded by PLIPSO4.57: 6 residues within 4Å:- Chain I: T.76, Q.77
- Chain J: K.78, G.80, K.81, V.82
Ligand excluded by PLIPSO4.60: 4 residues within 4Å:- Chain J: K.50, S.163, T.164
- Ligands: FEC.56
Ligand excluded by PLIPSO4.61: 2 residues within 4Å:- Chain J: S.144, N.148
Ligand excluded by PLIPSO4.62: 3 residues within 4Å:- Chain J: K.114
- Chain K: K.114
- Chain P: K.114
Ligand excluded by PLIPSO4.63: 3 residues within 4Å:- Chain J: P.161, S.162, S.163
Ligand excluded by PLIPSO4.66: 4 residues within 4Å:- Chain K: K.50, S.162, S.163, T.164
Ligand excluded by PLIPSO4.67: 2 residues within 4Å:- Chain K: S.144, N.148
Ligand excluded by PLIPSO4.68: 3 residues within 4Å:- Chain K: P.161, S.162, S.163
Ligand excluded by PLIPSO4.72: 6 residues within 4Å:- Chain L: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.69
Ligand excluded by PLIPSO4.73: 2 residues within 4Å:- Chain L: N.4, R.5
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain L: S.144, N.148
Ligand excluded by PLIPSO4.75: 3 residues within 4Å:- Chain L: P.161, S.162, S.163
Ligand excluded by PLIPSO4.76: 3 residues within 4Å:- Chain G: K.114
- Chain L: K.114
- Chain M: K.114
Ligand excluded by PLIPSO4.79: 3 residues within 4Å:- Chain M: K.50, T.164, G.165
Ligand excluded by PLIPSO4.80: 2 residues within 4Å:- Chain M: N.4, R.5
Ligand excluded by PLIPSO4.81: 3 residues within 4Å:- Chain M: S.144, K.147, N.148
Ligand excluded by PLIPSO4.82: 3 residues within 4Å:- Chain M: P.161, S.162, S.163
Ligand excluded by PLIPSO4.86: 5 residues within 4Å:- Chain N: K.50, S.163, T.164, G.165
- Ligands: FEC.83
Ligand excluded by PLIPSO4.87: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.37, SO4.137
Ligand excluded by PLIPSO4.88: 3 residues within 4Å:- Chain N: P.161, S.162, S.163
Ligand excluded by PLIPSO4.91: 5 residues within 4Å:- Chain O: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.92: 3 residues within 4Å:- Chain O: N.4, R.5, E.6
Ligand excluded by PLIPSO4.93: 3 residues within 4Å:- Chain O: S.144, K.147, N.148
Ligand excluded by PLIPSO4.94: 3 residues within 4Å:- Chain O: P.161, S.162, S.163
Ligand excluded by PLIPSO4.98: 5 residues within 4Å:- Chain P: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.99: 2 residues within 4Å:- Chain P: S.144, N.148
Ligand excluded by PLIPSO4.100: 3 residues within 4Å:- Chain P: P.161, S.162, S.163
Ligand excluded by PLIPSO4.103: 5 residues within 4Å:- Chain Q: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.104: 2 residues within 4Å:- Chain Q: S.144, N.148
Ligand excluded by PLIPSO4.105: 3 residues within 4Å:- Chain Q: P.161, S.162, S.163
Ligand excluded by PLIPSO4.107: 6 residues within 4Å:- Chain Q: T.76, Q.77
- Chain R: K.78, G.80, K.81, V.82
Ligand excluded by PLIPSO4.110: 4 residues within 4Å:- Chain R: K.50, S.163, T.164
- Ligands: FEC.106
Ligand excluded by PLIPSO4.111: 2 residues within 4Å:- Chain R: S.144, N.148
Ligand excluded by PLIPSO4.112: 3 residues within 4Å:- Chain R: K.114
- Chain S: K.114
- Chain X: K.114
Ligand excluded by PLIPSO4.113: 3 residues within 4Å:- Chain R: P.161, S.162, S.163
Ligand excluded by PLIPSO4.116: 4 residues within 4Å:- Chain S: K.50, S.162, S.163, T.164
Ligand excluded by PLIPSO4.117: 2 residues within 4Å:- Chain S: S.144, N.148
Ligand excluded by PLIPSO4.118: 3 residues within 4Å:- Chain S: P.161, S.162, S.163
Ligand excluded by PLIPSO4.122: 6 residues within 4Å:- Chain T: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.119
Ligand excluded by PLIPSO4.123: 2 residues within 4Å:- Chain T: N.4, R.5
Ligand excluded by PLIPSO4.124: 2 residues within 4Å:- Chain T: S.144, N.148
Ligand excluded by PLIPSO4.125: 3 residues within 4Å:- Chain T: P.161, S.162, S.163
Ligand excluded by PLIPSO4.126: 3 residues within 4Å:- Chain O: K.114
- Chain T: K.114
- Chain U: K.114
Ligand excluded by PLIPSO4.129: 3 residues within 4Å:- Chain U: K.50, T.164, G.165
Ligand excluded by PLIPSO4.130: 2 residues within 4Å:- Chain U: N.4, R.5
Ligand excluded by PLIPSO4.131: 3 residues within 4Å:- Chain U: S.144, K.147, N.148
Ligand excluded by PLIPSO4.132: 3 residues within 4Å:- Chain U: P.161, S.162, S.163
Ligand excluded by PLIPSO4.136: 5 residues within 4Å:- Chain V: K.50, S.163, T.164, G.165
- Ligands: FEC.133
Ligand excluded by PLIPSO4.137: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.37, SO4.87
Ligand excluded by PLIPSO4.138: 3 residues within 4Å:- Chain V: P.161, S.162, S.163
Ligand excluded by PLIPSO4.141: 5 residues within 4Å:- Chain W: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.142: 3 residues within 4Å:- Chain W: N.4, R.5, E.6
Ligand excluded by PLIPSO4.143: 3 residues within 4Å:- Chain W: S.144, K.147, N.148
Ligand excluded by PLIPSO4.144: 3 residues within 4Å:- Chain W: P.161, S.162, S.163
Ligand excluded by PLIPSO4.148: 5 residues within 4Å:- Chain X: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.149: 2 residues within 4Å:- Chain X: S.144, N.148
Ligand excluded by PLIPSO4.150: 3 residues within 4Å:- Chain X: P.161, S.162, S.163
Ligand excluded by PLIP- 12 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)
FEC.6: 20 residues within 4Å:- Chain A: R.20, L.24, H.28, M.31, Y.35, K.50, M.57, E.61, S.168
- Chain B: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.10
17 PLIP interactions:10 interactions with chain B, 7 interactions with chain A,- Hydrophobic interactions: B:I.27, B:M.31, B:E.61, A:L.24, A:E.61
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x FE2: FE (II) ION(Non-covalent)
- 90 x SO4: SULFATE ION(Non-functional Binders)
- 12 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)